Dra. Kathryn Foucar / kfoucar@salud.unm.edu
505-938-8456
Dr. Daniel Arber
Daniel Arber es profesor de Donald West y Mary Elizabeth King y presidente del Departamento de Patología de la Universidad de Chicago. Antes de mudarse a Chicago en 2016, fue Profesor Ronald F. Dorfman de Hematopatología en la Universidad de Stanford y Vicepresidente de Patología para Servicios Clínicos. Es autor de más de 300 artículos originales y capítulos de libros sobre hematopatología y diagnóstico molecular. Sus intereses de investigación incluyen la evaluación de marcadores de pronóstico y diagnóstico en la leucemia mieloide aguda. Fue asesor principal de la revisión de 2016 de la clasificación de la Organización Mundial de la Salud de neoplasias hematopoyéticas y linfoides y copresidió una iniciativa combinada del Colegio de Patólogos Estadounidenses y la Sociedad Estadounidense de Hematología para desarrollar pautas para el tratamiento de pacientes con leucemia aguda.
Adam Bagg, médico
Adam Bagg attended Medical School at the University of the Witwatersrand in South Africa, where he also completed his Pathology training in Laboratory Hematology/Hematopathology. He spent a decade at Georgetown University in Washington DC, where he repeated residency/fellowship training and subsequently joined the faculty, ultimately as Director of Hematopathology. Currently, Dr. Bagg is Professor of Pathology and Laboratory Medicine at the University of Pennsylvania, where he is Director of Hematology, and the Hematopathology Laboratory. For the past 11 years (2010-2020), he was voted by his peers as one of Philadelphia’s “Top Doctors” (as the only hematopathologist so noted). He was elected to Council/Board of Directors of USCAP for a 4-year term in 2011. Dr. Bagg has lectured extensively nationally (including at USCAP, ASCP, AMP, CAP, ACLPS, AACC, ISLH and ASH) and internationally (21 countries). He has over 200 publications, including peer-reviewed articles, invited reviews and textbook chapters, most in the realm of the molecular pathology of hematologic malignancies. He is an Associate Editor (for Hematopathology) of the Journal of Molecular Diagnostics and on the Editorial Board of Advances in Anatomic Pathology.
Dr. Carlos Buen-Ramos, MD, PhD
El Dr. Carlos Bueso-Ramos es Profesor en el Departamento de Hematopatología y Jefe de Sección del Laboratorio de Diagnóstico de Médula Ósea en el Centro de Cáncer MD Anderson de la Universidad de Texas, donde también se desempeña como miembro de la facultad en el Programa de Genética Diagnóstica en la Escuela de la UT. de Profesiones Sanitarias. Recibió su doctorado en medicina de la Universidad Autónoma de Honduras y su doctorado en la Facultad de Medicina de la Universidad de Emory, donde también completó su formación de residencia AP / CP. Completó su formación en Patología Quirúrgica y Hematopatología en el MD Anderson Cancer Center. El Dr. Bueso-Ramos fue miembro del Comité Asesor Clínico para la Revisión de la 4ª edición de la Clasificación de la OMS de neoplasias hematopoyéticas y linfoides. Sus intereses incluyen apoptosis y proliferación en leucemias y factores que afectan la regulación de la determinación del linaje celular, detención de la maduración y transformación en leucemias. Sus estudios actuales se centran en las citocinas hematopoyéticas y las proteínas de unión al ADN que regulan las vías NF-kB y p53.
Dra. Kathy Foucar
Dr. Foucar received her BS and MD degrees from Ohio State University, Columbus, Ohio, and her specialty training in AP/CP at the University of New Mexico and the University of Minnesota. She completed a surgical pathology fellowship at the University of Minnesota. She has over 45 years of practice in diagnostic hematopathology, and is the co-founder of the Hematopathology Fellowship at UNM and a founding member of the Society for Hematopathology. She is a Distinguished Professor of Pathology Emerita at the University of New Mexico Health Sciences Center. She is the author/co-author or editor of fifteen books on neoplastic and non-neoplastic hematopathology with an emphasis on blood and bone marrow, including the recently published 3rd edition of Diagnostic Pathology: Blood and Bone Marrow. She is the 2019 recipient of the Alumni Achievement Award from the Ohio State University School of Medicine and the 2023 recipient of the ASCP President’s Award.
Julia Geyer, MD
Dr. Julia Geyer is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine in New York City, where she is also clinical director of hematopathology service and past hematopathology fellowship director. Dr. Geyer went to medical school in Universidad Nacional Autonoma de Mexico (UNAM), a large public university in Mexico City. She then did AP/CP residency, followed by surgical pathology and hematopathology fellowship training, at the Massachusetts General Hospital. She serves on the editorial board of AJCP and has published >80 articles, predominantly in the area of bone marrow pathology.
Dr. Robert Hasserjian
Dr. Robert Hasserjian is a Professor of Pathology at Harvard Medical School and Massachusetts General Hospital, where he is Director of the Hematopathology Fellowship Program and is an Associate Director of the Pathology Residency Program. Dr. Hasserjian received his MD from Harvard and trained in Anatomic Pathology and Hematopathology at Brigham and Women's Hospital. Dr. Hasserjian is a Senior Reviewer for the update to the 4th edition of the WHO Classification of Myeloid Neoplasms and is currently the Vice President of the Society for Hematopathology. His research interests are in the discovery of pathologic and genetic features associated with the biologic behavior of myeloid and lymphoid neoplasms, particularly myelodysplastic syndromes and acute myeloid leukemia.
Eric Hsi, médico
Dr. Eric Hsi is a Professor of Pathology and Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, Rochester. Dr. Hsi received his MD degree and did his AP/CP and hematopathology training at the University of Michigan. He is an expert in diagnosis and classification of hematologic malignancy with interests in immunophenotyping and molecular hematopathology. His research interests include pre-clinical therapeutic assessment and biomarkers in lymphoma and leukemia. He has authored over 350 peer-reviewed manuscripts, edited a textbook in Hematopathology, serves on several editorial boards, and has held committee leadership positions for the College of American Pathologists, ALLIANCE, and American Society for Hematology.
Dr. Attilio Orazi
Attilio Orazi MD, FRCPath. (Engl.) is a Tenured Professor and Chair of the Department of Pathology at Texas Tech Health Sciences Center El Paso, Texas. He has published more than 290 articles and more than 30 book chapters. He is first, lead or co-author of four textbooks: Knowles’ Neoplastic Hematopathology; Illustrated Pathology of the Bone Marrow; Benign and Reactive Conditions of Lymph Node and Spleen; and Disorders of the Spleen. He was a Senior Advisor for the 2016 update of the 4th edition of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. He is a member of several editorial boards. His research interests include diagnostic integration and prognostic assessment in bone marrow and spleen pathology.
Kaaren Reichard, MD
Kaari Reichard is a Professor of Pathology at the Mayo Clinic in Rochester, MN where she is the Hematopathology residency rotation director, chair of the Hematopathology Education Oversight Committee, and former Chair of the Division of Hematopathology and Program Director for the Hematopathology Fellowship. Prior to joining the Mayo Clinic staff, she was on the faculty at the University of New Mexico which she joined after completing a Hematopathology fellowship at the University of Texas Southwestern Medical Center in Dallas and a Surgical Pathology Fellowship at Stanford University. In addition to her clinical duties Kaari has a strong interest in medical education, which includes teaching at all levels of graduate medical education and providing workshops/CME courses at national meetings. She received the Mayo Clinic Distinguished Educator award in 2022. She has participated in the authorship of several books on diagnostic Hematopathology, has authored over 100 book chapters and published over 120 peer-reviewed articles. Her research is focused on peripheral blood and bone marrow pathology and test utilization.
Dr. Wayne Tam, Doctor en Medicina
Dr. Tam received his MD and PhD degrees from the Weill Cornell Medicine Tri-institutional program. He completed a residency in Anatomic Pathology and a Hematopathology fellowship at Weill Cornell, and a research fellowship funded by the Leukemia and Lymphoma Society at the Institution of Cancer Genetics of Columbia University Medical Center. While at Weill Cornell he was the co-director of the Molecular Hematopathology Laboratory. He serves in the Editorial Board for Leukemia and Lymphoma. He is currently a Professor of Pathology and Laboratory Medicine at Donald Barbara Zucker School of Medicine, Hofstra/Northwell. His research interests are focused on the molecular pathogenesis of hematologic malignancies, in particular studies on clonal evolution and biomarker identification for drug resistance and relapse.
Sa A. Wang, MD
Dr. Wang is a professor of pathology and the section chief of Clinical Flow Cytometry, Department of Hematopathology, MD Anderson Cancer Center. Dr. Wang received her doctor degree in medicine and master degree in cancer immunology from Xiangya medical school (Hunan, China) in 1992. Dr. Wang completed a residency training in Anatomic pathology and Clinical Pathology at Yale University School of Medicine, and Hematopathology fellowship at Massachusetts General Hospital. Dr. Wang started her academic career at the University of Massachusetts Medical Center, and moved to MDACC in 2008. Dr. Wang’s clinical expertise and research interest include the use of histology, flow cytometry and molecular genetics for disease diagnosis, classification and risk stratification. Dr. Wang has published over 240 original study articles, >30 invited review articles and 27 book chapters for 7 reference books, and authored the book “Diagnosis of Blood and Bone Marrow Disorders” with Dr. Rob Hasserjian. Dr. Wang is an associate editor for Cytometry B Clinical Cytometry and a council member (2 terms) for the international flow cytometry society. Dr. Wang served as an expert panel member for a combined College of American Pathologist/American Society for Hematology initiative to develop guidelines for the work up of acute leukemia patients led by Dr. Dan Arber. Dr. Wang has obtained multiple industrial funds (>1 million) over her tenure at MDACC to study tumor biomarkers.
Dra. Olga K. Weinberg
Dr. Weinberg received her undergraduate degree from the University of Chicago followed by medical degree from Vanderbilt School of Medicine. She participated in Howard Hughes medical student fellowship at UCLA and subsequently did her residency training in anatomic pathology and a surgical pathology and hematopathology fellowships at Stanford University School of Medicine. Dr. Weinberg started her academic career at Boston Children’s Hospital and Brigham and Women’s hospital and recently moved to UT Southwestern Medical Center. She is an associate professor of pathology and a director of fellowship education at UTSW. Dr. Weinberg has served on numerous education committees including Society of Hematopathology, USCAP and International Clinical Cytometry Society and is currently a member of the executive committee of the Society of Hematopathology. She has co-organized a national Society of hematopathology workshop on “Molecular Genetics of Hematopoietic Neoplasms” in 2017 that was attended by over 400 hematopathologists. She has taught and directed numerous education courses including initiating a successful Harvard CME course ‘Current concepts in hematopathology’ in the Boston area and hematopathology short courses held at both USCAP and ASCP. On a clinical research side, she has a long standing interest in acute leukemias and myeloid neoplasms and published over 60 papers in well regarded journals including Modern pathology, American Journal of Hematology and Blood and presented her work at numerous national conferences including USCAP, ASH and ASCP. She has served on editorial boards of several well-known journals and co-authored numerous review papers and chapters.
Comuníquese con Kathryn Foucar, MD para obtener más información sobre el Grupo de patología de la médula ósea.
Dra. Kathryn Foucar
505-938-8456
kfoucar@salud.unm.edu